surpass 6 tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial ( SURPASS-CN-MONO) Time spent in glycaemic control – Time spent in glycaemic control
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



00187-5/asset/c6d4e658-f15b-417e-b7da-fadf005bf8cd/main.assets/gr3_lrg.jpg)



















